On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
Huge technical advances in molecular biology and big data biology are leading us towards a ‘forth industrial revolution’ with the ongoing development of novel genetic engineering techniques being reviewed by the UN Conventions for Biological Diversity, under the term ‘synthetic biology’.
In December 2016 Monsanto shareholders voted in favour of the sale of the company to Bayer for US$66 billion, making it the largest-ever foreign corporate takeover by a German company. Both Bayer and Monsanto are major global manufacturers of agrochemicals and seeds, including genetically modified seed.
This is a briefing about power and control in our food system, focusing chiefly on South Africa's staple food, maize. It shows how a select group of companies, including Tiger Brands, Pioneer and Premier Foods commandeer the entire maize value chain and continue to squeeze the poorest South Africans.
Across the world, the use of bilateral trade instruments to prise open markets for genetically modified (GM) crops is escalating. To expand business overseas, the biotech industry needs stronger intellectual property rules and weaker biosafety standards. Bilateral trade deals are an effective way to do this.
'Marker Assisted Selection' uses molecular markers as tools in a plant or animal breeding programme to select for important agricultural traits, such as nutritional quality, drought tolerance, disease and pest resistance.